Analysis of HIV/AIDS Model with risk compensation effects among Pre-Exposure Prophylaxis users and infectious immigrants
Abstract
Pre-Exposure Prophylaxis (PrEP) is a promising HIV prevention strategy, and its provision has grown rapidly in several countries, including those in Sub-Saharan Africa. However, lingering concerns remain that introducing PrEP may lead to unintended consequences, such as decreased adherence to other prevention methods and increased risky sexual behaviour, culminating in risk compensation. This study employs a six-compartment mathematical model to investigate the effects of risk compensation behaviour among PrEP users in a population with an influx of infectious immigrants. The model exhibits only disease-free equilibrium points in the absence of infective immigrants and endemic equilibrium with the influx of infected immigrants. The disease-free equilibrium point exists and is locally and globally asymptotically stable in the absence of infective immigrants when the basic reproduction number is less than one. In contrast, the model exhibits only endemic equilibrium in the presence of infective immigrants, which is asymptotically stable when basic reproduction number exceeds unity. A sensitivity analysis of the parameters associated with R1 was performed using the normalized forward sensitivity index to determine the most influential parameter. The analysis revealed that the number of sexual partners had the greatest influence on disease endemicity. Numerical simulations supported the analytical findings, showing that risk compensation undermines PrEP effectiveness and that multiple sexual partners increase new HIV infections. However, PrEP can significantly reduce new infections in a population with varying immigrant influx and no risk compensation behaviour, highlighting its potential impact in controlling HIV spread. The effectiveness of PrEP depends on strict adherence to usage in combination with other preventive measures. The disease persists with the inflow of infective immigrants.
Keywords
Full Text:
PDFReferences
UNAIDS, “FACT SHEET 2025, Global HIV statistics,” https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf, 2025, Accessed on 15 August 2025.
WHO, “The Global Health Observatory,” https://www.who.int/data/gho/data/themes/hiv-aids, 2025, Accessed on 15 August 2025.
M. Coffee, M. N. Lurie, and G. P. Garnett, “Modelling the impact of migration on the hiv epidemic in south africa,” Aids, vol. 21, no. 3, pp. 343–350, 2007. DOI:10.1097/QAD.0b013e328011dac9
UNAIDS, “Prevention,” http://www.unaids.org/en/topic/prevention, 2022, Accessed on 15 August 2025.
F. Brauer and P. van den Driessche, “Models for transmission of disease with immigration of infectives,” Mathematical Biosciences, vol. 171, no. 2, pp. 143–154, 2001. DOI:10.1016/S0025-5564(01)00057-8
I. Shabani, E. S. Massawe, and O. D. Makinde, “Modelling the effect of screening on the spread of hiv infection in a population with variable inflow of infective immigrants,” vol. 6, no. 20, pp. 4397–4405, 2011. DOI:10.5897/SRE11.385
R. Naresh, A. Tripathi, and D. Sharma, “Modelling and analysis of the spread of aids epidemic with immigration of hiv infectives,” Mathematical and computer modelling, vol. 49, no. 5–6, pp. 880–892, 2009. DOI:10.1016/j.mcm.2008.09.013
M. I. Daabo and B. Seidu, “Modelling the effect of irresponsible infective immigrants on the transmission dynamics of HIV/AIDS,” vol. 3, no. 1, pp. 31–40, 2012.
M. S. Cohen, M. McCauley, and J. Sugarman, “Establishing hiv treatment as prevention in the hiv prevention trials network 052 randomized trial: an ethical odyssey,” Clinical trials, vol. 9, no. 3, pp. 340–347, 2012. DOI:10.1177/1740774512443594
WHO, “WHO Expands its Recommendation on the use of oral PrEP on HIV infection,” https://iris.who.int/bitstream/handle/10665/197906/WHO_HIV_2015.48_en g.pdf, 2015, Accessed on 15 August 2025.
R. J. Landovitz et al., “Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk hiv-uninfected individuals: Hptn 077, a phase 2a randomized controlled trial,” PLoS medicine, vol. 15, no. 11, p. e1002690, 2018. DOI:10.1371/journal.pmed.1002690
WHO, “WHO Recommends Long-Acting Cabotegravir for HIV Prevention,” https://www.who.int/news/item/28-07-2022-who-recommends-long-acting-cabotegravir-for-hiv-prevention, 2022, Accessed on 15 August 2025.
R. J. Landovitz et al., “Cabotegravir for hiv prevention in cisgender men and transgender women,” New England Journal of Medicine, vol. 385, no. 7, pp. 595–608, 2021. DOI:10.1056/NEJMoa2101016
S. M. Jenness et al., “Individual hiv risk versus population impact of risk compensation after hiv preexposure prophylaxis initiation among men who have sex with men,” PloS one, vol. 12, no. 1, p. e0169484, 2017. DOI:10.1371/journal.pone.0169484
M. S. Cohen, T. Gamble, and M. McCauley, “Prevention of hiv transmission and the hptn 052 study,” Annual Review of Medicine, vol. 71, no. 1, pp. 347–360, 2020. DOI:10.1146/annurev-med-110918-034551
L. Wang, A. Din, and P. Wu, “Dynamics and optimal control of a spatial diffusion hiv/aids model with antiretrovial therapy and pre-exposure prophylaxis treatments,” Mathematical Methods in the Applied Sciences, vol. 45, no. 16, pp. 10136–10161, 2022. DOI:10.1002/mma.8359
M. W. Traeger et al., “Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis,” Clinical Infectious Diseases, vol. 67, no. 5, pp. 676–686, 2018. DOI:10.1093/cid/ciy182
A. Ugarte et al., “Evolution of risk behaviors, sexually transmitted infections and prep care continuum in a hospital-based prep program in barcelona, spain: a descriptive study of the first 2 years’ experience,” Infectious Diseases and Therapy, vol. 12, pp. 425–442, 2023. DOI:10.1007/s40121-022-00733-6
A. R. da Costa et al., “Substance use and risky sexual behavior in the prep outpatient clinic at the university hospital of brasilia,” Tropical Medicine and Infectious Disease, vol. 8, no. 6, p. 323, 2023. DOI:10.3390/tropicalmed8060323
M. B. Moreau et al., “Hiv self-testing implementation, distribution and use among female sex workers in cotonou, benin: a qualitative evaluation of acceptability and feasibility,” BMC Public Health, vol. 22, no. 1, p. 589, 2022. DOI:10.1186/s12889-022-12917-3
P. Luehring-Jones et al., “Pre-exposure prophylaxis (prep) use is associated with health risk behaviors among moderate-and heavy- drinking msm,” AIDS Education and Prevention, vol. 31, no. 5, pp. 452–462, 2019. DOI:10.1521/aeap.2019.31.5.452
P. A. Shuper et al., “Acute Alcohol Consumption Directly Increases HIV Transmission Risk: A Randomized Controlled Experiment,” Journal of Acquired Immune Deficiency Syndromes, vol. 76, no. 5, pp. 493–500, 2017. DOI:10.1097/QAI.0000000000001549
N. Georgiadis et al., “The impact of hiv preexposure prophylaxis on bacterial sexually transmitted infection occurrence in msm: a systematic review and meta-analysis,” AIDS, vol. 38, no. 7, pp. 1033–1045, 2024. DOI:DOI: 10.1097/QAD.0000000000003837
A. Rodrigues et al., “Substance Use and Risky Sexual Behavior in the PrEP Outpatient Clinic at the University Hospital of Brasília,” Trop. Med. Infect. Dis., vol. 8, no. 6, p. 323, 2023, DOI:10.3390/tropicalmed8060323
K. H. Mayer, A. Agwu, and D. Malebranche “Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.” Advances in therapy, vol. 37, no. 5, pp. 1778–1811, 2020. DOI:10.1007/s12325-020-01295-0
W. Fang et al., “Efficacy, adherence and side effects of PrEP for HIV-1 prevention,” Int. J. Biology, vol. 11, no. 4, pp. 80–87, 2019. DOI:10.5539/ijb.v11n4p80
J. D. Markley, “Pre-Exposure Prophylaxis for HIV: Bioethical, Clinical, and Epidemiological Considerations,” The Linacre Quarterly, vol. 91, no. 4, pp. 386–402, 2024. DOI:10.1177/0024363924123906
P. T. Djomegni, A. Tekle, and M. Y. Dawed, “Pre-exposure prophylaxis hiv/aids mathematical model with non classical isolation,” Japan journal of industrial and applied mathematics, vol. 37, no. 3, pp. 781–801, 2020. DOI:10.1007/s13160-020-00422-2
S. Saha and G. Samanta, “Modelling and optimal control of hiv/aids prevention through prep and limited treatment,” Physica A: Statistical Mechanics and its Applications, vol. 516, pp. 280–307, 2019. DOI:10.1016/j.physa.2018.10.033
S. J. Gutowska, K. Hoffman, and K. Gurski, “The effect of prep uptake and adherence on the spread of hiv in the presence of casual and long-term partnerships,” Mathematical Biosciences and Engineering, vol. 19, no. 12, pp. 1903–11934, 2022. DOI:10.3934/mbe.2022555
Y. Luo et al., “Role of art and prep treatments in a stochastic hiv/aids epidemic model,” Mathematics and Computers in Simulation, vol. 221, pp. 337–357, 2024. DOI:10.1016/j.matcom.2024.03.010
H. Choi et al., “Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study,” Scientific Reports, vol. 10, no. 1, pp. 1–11, 2020. DOI:10.1038/s41598-020-71565-y
E. F. Drabo et al., “A cost-effectiveness analysis of preexposure prophylaxis for the prevention of hiv among los angeles county men who have sex with men,” Clinical Infectious Diseases, vol. 63, no. 11, pp. 1495–1504, 2016. DOI:10.1093/cid/ciw578
C. J. Silva and D. F. Torres, “Modeling and optimal control of hiv/aids prevention through prep,” Discrete and Continuous Dynamical Systems – Series S, vol. 11, no. 1, pp. 119–141, 2018, DOI:10.3934/dcdss.2018008.
J. Oladejo and T. Oluyo, “Effects of prep on the hiv/aids dynamics with of immigration of infectives,” International Journal of Mathematical Analysis and Modelling, vol. 5, no. 2, pp. 36–54, 2022.
E. M. D. Moya and D. S. Rodrigues, “Fractional order modeling for injectable and oral hiv pre-exposure prophylaxis,” epidemiology, vol. 3, no. 2, pp. 139–151, 2023. DOI:10.3934/mmc.2023013
Z. Chazuka, E. Mudimu, and D. Mathebula, “Stability and bifurcation analysis of an hiv model with pre-exposure prophylaxis and treatment interventions,” Scientific African, vol. 23, p. e01979, 2024. DOI:10.1016/j.sciaf.2023.e01979
C. E. Lyons et al., “Modeling the potential impact of pre-exposure prophylaxis for hiv among men who have sex with men in cameroon,” BMC infectious diseases, vol. 22, no. 1, p. 751, 2022. DOI:10.1186/s12879-022-07738-z
J. Li et al., “A mathematical model of biomedical interventions for hiv prevention among men who have sex with men in china,” BMC infectious diseases, vol. 18, p. 600, 2018. DOI:10.1186/s12879-018-3516-8
UNAIDS, “2023 Global HIV & AIDS Statistics-Fact Sheet," https://www.unaids.org/en/resources/fact-sheet, 2022, Accessed on 15 August 2025.
T. T. Tegegne, P. R. Koya, and T. T. Mekonnen, “Modeling the Combined Effect of Vertical Transmission and Variable Inflow of Infective Immigrants on the Dynamics of HIV/AIDS,” American Journal of Applied Mathematics, vol. 4, no. 1, pp. 11–19, 2016. DOI:10.11648/j.ajam.20160401.12
M. I. Daabo, O. D. Makinde, and B. Seidu, “Modeling the combined effects of careless susceptible and infective immigrants on the transmission dynamics of hiv/aids epidemics,” Journal of Public Health and Epidemiology, vol. 5, no. 9, pp. 362–369, 2013.
E. Shim, “An epidemic model with immigration of infectives and vaccination,” [Ph.D. dissertation]. University of British Columbia, 2004.
H. A. Fatahillah and D. Aldila, “Forward and backward bifurcation analysis from an imperfect vaccine efficacy model with saturated treatment and saturated infection,” Jambura Journal of Biomathematics (JJBM), vol. 5, no. 2, pp. 132–143, 2024. DOI:10.37905/jjbm.v5i2.28810
T. Oluyo et al., “Mathematical modelling and analysis of lassa fever dynamics with environmental transmission and reinfection,” Franklin Open, vol. 11, p. 100254, 2025. DOI:10.1016/j.fraope.2025.100254
P. Z. Kamalia and D. Aldila, “Epidemic dynamics with nonlinear incidence considering vaccination effectiveness,” Jambura Journal of Biomathematics (JJBM), vol. 6, no. 3, pp. 222–233, 2025. DOI:10.37905/jjbm.v6i3.33815
D. Okuonghae and A. Omame, “Analysis of a mathematical model for covid-19 population dynamics in lagos, nigeria,” Chaos, Solitons & Fractals, vol. 139, p. 110032, 2020. DOI:10.1016/j.chaos.2020.110032
S.-J. Fan and L. Jiang, “A generalized comparison theorem for bsdes and its applications,” Journal of Theoretical Probability, vol. 25, no. 1, pp. 50–61, 2012. DOI:10.1007/s10959-010-0293-8
P. Van Den Driessche and J. Watmough, “Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission,” Mathematical Biosciences, vol. 180, no. 1–2, pp. 29–48, 2002. DOI:10.1016/S0025-5564(02)00108-6
O. Diekmann, J. A. P. Heesterbeek, and J. A. J. Metz, “On the definition and the computation of the basic reproduction ratio r0 in models for infectious diseases in heterogeneous populations,” Journal of mathematical biology, vol. 28, pp. 365–382, 1990. DOI:10.1007/BF00178324
X. Wang, “A simple proof of descartes’s rule of signs,” The American Mathematical Monthly, vol. 111, no. 6, pp. 525–526, 2004. DOI:10.1080/00029890.2004.11920108
J. D. Murray, “Mathematical Biology I: An Introduction (3rd ed.)." New York: Springer, 2002. DOI:10.1007/b98868
C. Castillo-Chavez and B. Song, “Dynamical models of tuberculosis and their applications,” Mathematical Biosciences & Engineering, vol. 1, no. 2, pp. 361–404, 2004. DOI:10.3934/mbe.2004.1.361
P. A. Naik et al., “Modeling the transmission dynamics of covid-19 pandemic in caputo type fractional derivative,” Journal of Multiscale Modelling, vol. 12, no. 3, p. 2150006, 2021. DOI:10.1142/S1756973721500062
M. O. Adeyemi, T. O. Oluyo, and J. K. Oladejo, “Modelling the transmission and control dynamics of coronavirus disease with social distancing and contact tracing,” International Journal of Innovative Science and Research Technology, vol. 5, no. 5, pp. 948–964, 2020.
J. P. LaSalle, “Stability theory and invariance principles,” in Dynamical Systems, vol. 1, pp. 211–222, 1976. DOI:10.1016/B978-0-12-164901-2.50021-0
N. Chitnis, J. M. Hyman, and J. M. Cushing, “Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model,” Bulletin of mathematical biology, vol. 70, no. 5, pp. 1272–1296, 2008. DOI:10.1007/s11538-008-9299-0
UN, “Countries in the World by Population,” https://www.worldometers.info/world-population/nigeria-population/, 2023, Accessed on 15 August 2025.
UNAIDS, “Country Factsheet: Nigeria 2023 - HIV and AIDS Estimates,” https://www.unaids.org/en/regionscountries/countries/nigeria, 2023, Accessed on 15 August 2025.
UNAIDS, “Country Progress Report-Nigeria: Global AIDS Monitoring 2020,” https://www.unaids.org/sites/default/files/country/document/NGA_2020_countryreport, 2021, Accessed on 15 August 2025.
DOI: https://doi.org/10.37905/jjbm.v6i4.30812
Copyright (c) 2025 Janet kikelomo Oladejo, Abiodun Adewale Taiwo, Sefiyat Opeyemi Fawale, Temidayo Joseph Oluwafemi

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Jambura Journal of Biomathematics (JJBM) has been indexed by:
EDITORIAL OFFICE OF JAMBURA JOURNAL OF BIOMATHEMATICS |
![]() | Department of Mathematics, Faculty of Mathematics and Natural Science, Universitas Negeri Gorontalo Jl. Prof. Dr. Ing. B. J. Habibie, Moutong, Tilongkabila, Kabupaten Bone Bolango 96554, Gorontalo, Indonesia |
![]() | Email: [email protected] |
![]() | Jambura Journal of Biomathematics (JJBM) by Department of Mathematics Universitas Negeri Gorontalo is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Powered by Public Knowledge Project OJS. |


















